a
a
Weather:
No weather information available
HomeHealthAtezolizumab plus bevacizumab and chemotherapy in metastatic nonsquamous NSCLC: the randomized double-blind phase 3 IMpower151 trial

Atezolizumab plus bevacizumab and chemotherapy in metastatic nonsquamous NSCLC: the randomized double-blind phase 3 IMpower151 trial

Nature Medicine, Published online: 16 May 2025; doi:10.1038/s41591-025-03658-y

In the IMpower151 trial, the drug combination previously shown to be effective in the IMpower150 trial was not significantly effective in a Chinese population.

No comments

Sorry, the comment form is closed at this time.

Translate »